Literature DB >> 6763789

The purification of gametocytes of Plasmodium falciparum and P. yoelii nigeriensis by colloidal silica (Percoll) gradient centrifugation.

A Knight, R E Sinden.   

Abstract

Percoll gradient centrifugation has been applied to Plasmodium falciparum- and P. yoelii-infected blood to allow rapid concentration of gametocytes. In the case of cultured P. falciparum, stage IV and V gametocytes were separated from immature stage II and III forms and concentrated from initial gametocytaemias of 1 to 3% to an average of greater than 80% and a maximum of 100% purity in a fraction which collected at the 1.064/1.083 g/ml interface; the rounded gametocytes of P. yoelii-infected mouse blood were also concentrated in this fraction. A much larger enrichment in microgametocyte concentration (average of 160-fold) was recorded in a fraction that collected at the 1.047/1.064 g/ml interface. The large increases in gametocyte concentration were paralleled by similarly large increases in exflagellation activity, thus confirming the viability of both preparations.

Entities:  

Mesh:

Year:  1982        PMID: 6763789     DOI: 10.1016/0035-9203(82)90150-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

1.  Parasite-induced processes for adenosine permeation in mouse erythrocytes infected with the malarial parasite Plasmodium yoelii.

Authors:  W P Gati; A N Lin; T I Wang; J D Young; A R Paterson
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

2.  Soft X-ray microscopy analysis of cell volume and hemoglobin content in erythrocytes infected with asexual and sexual stages of Plasmodium falciparum.

Authors:  Eric Hanssen; Christian Knoechel; Megan Dearnley; Matthew W A Dixon; Mark Le Gros; Carolyn Larabell; Leann Tilley
Journal:  J Struct Biol       Date:  2011-09-16       Impact factor: 2.867

3.  Role of T cells in preventing transmission of rodent malaria.

Authors:  P G Harte; N C Rogers; G A Targett
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

4.  Functional analysis of the exported type IV HSP40 protein PfGECO in Plasmodium falciparum gametocytes.

Authors:  Belinda J Morahan; Carolyn Strobel; Uzma Hasan; Beata Czesny; Pierre-Yves Mantel; Matthias Marti; Saliha Eksi; Kim C Williamson
Journal:  Eukaryot Cell       Date:  2011-09-30

5.  Oxygen radical release by adherent cell populations during the initial stages of a lethal rodent malarial infection.

Authors:  A O Wozencraft; S L Croft; G Sayers
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

6.  Optimized in vitro production of Plasmodium vivax ookinetes.

Authors:  Colleen M McClean; Haydee Guerra Alvarado; Victor Neyra; Alejandro Llanos-Cuentas; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

7.  Characterization and pathological significance of monoclonal DNA-binding antibodies from mice with experimental malaria infection.

Authors:  C M Lloyd; I Collins; A J Belcher; N Manuelpillai; A O Wozencraft; N A Staines
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Killing of human malaria parasites by macrophage secretory products.

Authors:  A O Wozencraft; H M Dockrell; J Taverne; G A Targett; J H Playfair
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides.

Authors:  Victor Barbosa Saraiva; Leandro de Souza Silva; Claudio Teixeira Ferreira-DaSilva; João Luiz da Silva-Filho; André Teixeira-Ferreira; Jonas Perales; Mariana Conceição Souza; Maria das Graças Henriques; Celso Caruso-Neves; Ana Acacia de Sá Pinheiro
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

10.  Isolation of Plasmodium berghei ookinetes in culture using Nycodenz density gradient columns and magnetic isolation.

Authors:  Victoria Carter; Hazel C Cable; B Ann Underhill; Jackie Williams; Hilary Hurd
Journal:  Malar J       Date:  2003-11-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.